MARKET

IDXG

IDXG

Interpace Biosciences
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.4500
+0.0206
+4.80%
After Hours: 0.4550 +0.005 +1.11% 17:35 12/09 EST
OPEN
0.4396
PREV CLOSE
0.4294
HIGH
0.4600
LOW
0.4300
VOLUME
111.37K
TURNOVER
--
52 WEEK HIGH
1.116
52 WEEK LOW
0.3810
MARKET CAP
17.19M
P/E (TTM)
-0.7480
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of IDXG and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

IDXG News

  • Interpace Biosciences Expands Strategic Partnership Activities with Genecast Biotechnology in China
  • GlobeNewswire.4d ago
  • Edited Transcript of IDXG earnings conference call or presentation 13-Nov-19 9:30pm GMT
  • Thomson Reuters StreetEvents.5d ago
  • Interpace Biosciences Launches New Corporate Website
  • GlobeNewswire.12/02 11:55
  • The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen
  • Benzinga.11/27 12:26

More

Industry

Business Support Services
-0.51%
Professional & Commercial Services
-0.47%

Hot Stocks

Name
Price
%Change

About IDXG

Interpace Biosciences, Inc., formerly Interpace Diagnostics Group, Inc., is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. The Company operates through molecular diagnostics segment. It offers molecular tests, such as PancraGen, which is a pancreatic cyst molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its PathFinder platform; ThyGenX, which assesses thyroid nodules for risk of malignancy, and ThyraMIR, which assesses thyroid nodules risk of malignancy utilizing a gene expression assay. Through its molecular diagnostics business, it provides diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers, which are focused on early detection of cancer.
More

Webull offers Interpace Biosciences Inc (IDXG) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.